Microsaic Systems Share Discussion Threads

[pwal] 12/6/2023 11:05

So results on or before 30th June.Not long now.

[zxie] 23/5/2023 16:48

30m loading

[cocker] 22/5/2023 13:55

Audit delay possibly done to allow mates to exit before the final curtain comes down!. You don't have to be Einstein to see the big trades flying through whilst penny punters pick up the stock, what is surprising is how well the share price has done considering the amounts being dumped.

[owenski] 17/5/2023 18:34

Everything GB touches, lol

[onehanded] 17/5/2023 18:13

looks like GB trying to offload all his shares with TP as well. Maybe they will bid for DVRG LOL. Expect any holders here will be selling and moving on as now 'a dead duck'

[alancapone] 17/5/2023 16:29

That's why I got out. Should be locked up in my opinion.

[dr biotech] 17/5/2023 16:18

15 May '23 - 11:40 - 1101 of 1107
0 4 1
Firstly, the claim that "the product just isn't strong enough" is not supported by the fact that Microsaic Systems has successfully sold its instruments to several clients, including multinational corporations like Pfizer and AstraZeneca, as well as government institutions like the UK's National Health Service (NHS).

How many have the sold? less than 10 a year? Total sales since I posted the above about 5 years ago are about £2.5m Loss that year alone was £2.8m so nowhere near enough







Furthermore, the ongoing partnership with Avacta Group, a UK-based biotech company, shows that there is a potential for the technology to be used in high-throughput drug discovery, which can lead to substantial growth opportunities. It is also worth noting that the contract with Avacta is ongoing, which indicates that the partnership has been successful so far.

In terms of revenue, although Microsaic Systems reported a revenue of £0.4 million in 2021, it is important to consider the fact that the company has only recently started commercializing its products.

Its been 5 years since I posted the above. They also signed many distributor agreements - such as with Omicron in the UK. You can give them a ring and ask how many they sold (0).



Regarding the claim that the company should delist and become a small service company, it is worth noting that the company has been actively expanding its product portfolio. For example, in 2021, Microsaic Systems announced the launch of its second product line, the 4500 MiD, which is a more advanced version of its previous product. This indicates that the company is still investing in product development and is not solely focused on becoming a service company.

Yes, but their is no evidence these will sell either.



In terms of the claim that Microsaic's technology is not game-changing, it is important to note that the company's instruments offer advantages such as portability and speed, which are not found in traditional LC/MS systems. These advantages make the technology appealing to a variety of clients, particularly those in the pharmaceutical and biotech industries.

Portability offers no benefits to the pharmaceutical industry. In a pharma lab every piece of equipment has to be qualified to show its working as it should. If a piece of equipment is moved, even from one bench to another it needs to be requalified (it takes a day and cost about £1k). The samples go to the lab, the lab doesn't go to the sample. May be some use monitoring river water etc, but I don't work in that area.






Overall, while there are challenges facing Microsaic Systems, such as competition from established players in the industry, there is evidence to suggest that the company has the potential for growth and success in the future. .................................................................................... Also just collected facts: DeepVerge plc: Microsaic has a collaboration agreement with DeepVerge, a company specializing in AI-powered microbial detection and diagnostics. Under the agreement, Microsaic's mass spectrometry technology is integrated with DeepVerge's AI platform to develop a solution for rapid detection and identification of microbial contamination. The collaboration was announced in 2020 and continues as of 2021.

Unimicro Technologies Inc.: In 2018, Microsaic signed an agreement with Unimicro Technologies Inc., a Chinese distributor of scientific equipment. Under the agreement, Unimicro became Microsaic's exclusive distributor for the MiD product line in China, Hong Kong, and Taiwan. The agreement has a three-year term with an option to extend for a further two years.

Avacta Group plc: In 2019, Microsaic signed an agreement with Avacta Group plc, a UK-based biotech company. Under the agreement, Microsaic's mass spectrometry technology is integrated with Avacta's Affimer reagents to develop a high-throughput screening platform for drug discovery. The collaboration is ongoing as of 2021.

Process Instruments & Components, Inc.: In 2021, Microsaic announced a distribution agreement with Process Instruments & Components, Inc., a US-based distributor of scientific equipment. Under the agreement, Process Instruments & Components became Microsaic's exclusive distributor for the MiD product line in the United States. The agreement has an initial term of two years.

Waters Corporation: In 2016, Microsaic signed a collaboration agreement with Waters Corporation, a US-based manufacturer of analytical instruments. Under the agreement, Microsaic's technology was integrated with Waters' mass spectrometry systems to provide a high-throughput solution for drug discovery. The collaboration ended in 2019.

Green Energy Technology Inc.: In 2016, Microsaic signed a distribution agreement with Green Energy Technology Inc., a Taiwanese distributor of scientific equipment. Under the agreement, Green Energy became Microsaic's exclusive distributor for the MiD product line in Taiwan. The agreement ended in 2018.


Why did so many of these agreements end? Because they couldn't sell it. Anyway I'll leave you all to it.

[daveboy19] 17/5/2023 15:00

Safely lured yonks ago - not content, they want more.

[owenski] 17/5/2023 13:39

I wouldn't touch anything with Brandon involved and post 1101 smells like a manager posting as a PI to lure in numpties whilst everyone else is dumping.

Bargepole.

[onehanded] 17/5/2023 12:56

looks like GB trying to offload all his shares with TP as well. Maybe they will bid for DVRG LOL. Expect any holders here will be selling and moving on as now 'a dead duck'

[daveboy19] 15/5/2023 15:02

I don't know much nowadays except everyone seems to be trying to pull a fast one on somebody else!!
I feared the worst when former CEO left for 'pastures new' after describing .10p as very disappointing with the tech they have.
I'm stuck in much higher after the likes of Nyboy have long since pumped and perished which goes back full circle to the first sentence.

[cocker] 15/5/2023 13:53

One post from the guy who I suspect to be the mainman himself, don't you?.

[sultan_md_uk] 15/5/2023 10:40

Firstly, the claim that "the product just isn't strong enough" is not supported by the fact that Microsaic Systems has successfully sold its instruments to several clients, including multinational corporations like Pfizer and AstraZeneca, as well as government institutions like the UK's National Health Service (NHS).

Furthermore, the ongoing partnership with Avacta Group, a UK-based biotech company, shows that there is a potential for the technology to be used in high-throughput drug discovery, which can lead to substantial growth opportunities. It is also worth noting that the contract with Avacta is ongoing, which indicates that the partnership has been successful so far.

In terms of revenue, although Microsaic Systems reported a revenue of £0.4 million in 2021, it is important to consider the fact that the company has only recently started commercializing its products. Additionally, partnerships with major players in the industry can lead to significant revenue growth in the future.

Regarding the claim that the company should delist and become a small service company, it is worth noting that the company has been actively expanding its product portfolio. For example, in 2021, Microsaic Systems announced the launch of its second product line, the 4500 MiD, which is a more advanced version of its previous product. This indicates that the company is still investing in product development and is not solely focused on becoming a service company.

In terms of the claim that Microsaic's technology is not game-changing, it is important to note that the company's instruments offer advantages such as portability and speed, which are not found in traditional LC/MS systems. These advantages make the technology appealing to a variety of clients, particularly those in the pharmaceutical and biotech industries.

Overall, while there are challenges facing Microsaic Systems, such as competition from established players in the industry, there is evidence to suggest that the company has the potential for growth and success in the future. .................................................................................... Also just collected facts: DeepVerge plc: Microsaic has a collaboration agreement with DeepVerge, a company specializing in AI-powered microbial detection and diagnostics. Under the agreement, Microsaic's mass spectrometry technology is integrated with DeepVerge's AI platform to develop a solution for rapid detection and identification of microbial contamination. The collaboration was announced in 2020 and continues as of 2021.

Unimicro Technologies Inc.: In 2018, Microsaic signed an agreement with Unimicro Technologies Inc., a Chinese distributor of scientific equipment. Under the agreement, Unimicro became Microsaic's exclusive distributor for the MiD product line in China, Hong Kong, and Taiwan. The agreement has a three-year term with an option to extend for a further two years.

Avacta Group plc: In 2019, Microsaic signed an agreement with Avacta Group plc, a UK-based biotech company. Under the agreement, Microsaic's mass spectrometry technology is integrated with Avacta's Affimer reagents to develop a high-throughput screening platform for drug discovery. The collaboration is ongoing as of 2021.

Process Instruments & Components, Inc.: In 2021, Microsaic announced a distribution agreement with Process Instruments & Components, Inc., a US-based distributor of scientific equipment. Under the agreement, Process Instruments & Components became Microsaic's exclusive distributor for the MiD product line in the United States. The agreement has an initial term of two years.

Waters Corporation: In 2016, Microsaic signed a collaboration agreement with Waters Corporation, a US-based manufacturer of analytical instruments. Under the agreement, Microsaic's technology was integrated with Waters' mass spectrometry systems to provide a high-throughput solution for drug discovery. The collaboration ended in 2019.

Green Energy Technology Inc.: In 2016, Microsaic signed a distribution agreement with Green Energy Technology Inc., a Taiwanese distributor of scientific equipment. Under the agreement, Green Energy became Microsaic's exclusive distributor for the MiD product line in Taiwan. The agreement ended in 2018.

[cocker] 15/5/2023 10:11

New date as auditors trying to make head nor tail of deceit?

[pwal] 15/5/2023 07:20

New date. End of June.

[pwal] 28/4/2023 08:14

I'm thinking end of May.

[pwal] 28/4/2023 07:12

Anyone know the reporting date?

[dr biotech] 26/4/2023 09:37

Its been a long time since I posted on here. This company was never going to succeed, the product just isn't strong enough. I felt that at the time and whilst was always an outside chance they could license it to a major player its never happened. I think the share price was about 2p when I posted so this joins the 99% club. I've had plenty of failures similar to that and its not nice.

Looking forward it could become a small service company - but they are going to need to slim down and I'd even say delist as the time/cost of a listing may become more trouble than its worth. Good luck to those that retain the faith.








Dr Biotech - 04 Sep 2018 - 10:32:02 - 669 of 1096 Microsaic Systems - 2018 - MSYS
I wouldn't touch these.

Their single quad MS is interesting tech, but not game changing. It doesn't offer the resolution of a benchtop - it can't match a triple Quad for flexibility (or the capability for MS/MS) and it doesn't have the mass range of a ToF which is often better for large biomolecules.

I've been to a lot of production facilities in the UK and they all have full LC/MS systems to hand. A new LCMS costs around £150k (you can pick up a decent used system for about 30-40k. They are moderately complex and need someone who knows what they are doing, but once set up they can run samples every few minutes (uplc). I don't know of any manufacturers with off site facilities (admittedly as I work with the labs I wouldn't go to a site without a lab).

I know the people at Omicron in the UK. They are a small distributor with a handful of employees. I see them regularly enough and will ask them if they have had any traction with their customers.

Looking at the results I wonder if they will ever sell enough to cover their expenses. I'm not sure they will ever turn in a profit.

I hope I am wrong - the UK has a strong history in MS and it would be nice to see them succeed, but I won't be putting my money on it.

[fanon7] 23/4/2023 14:29

- Cash of £0.8M, plus accurals of £0.5M, total £1.3M
- 'Slow start to year',
- Burn rate about £150k pm.
- Pipeline (not order book) of £2M,
- Auditors looking at debt and 'disclosures' (May write off the DRVG £1.4M as bad debt),
- DVRG has £1M cash (insolvent),

[pwal] 20/4/2023 11:41

Results end of May?Positive news I hope.